Tirzepatide
Dual GIP and GLP-1 Receptor Agonist
Tirzepatide is a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist. Available as FDA-approved Mounjaro® for Type 2 diabetes and Zepbound® for weight management and obstructive sleep apnea. It provides superior weight loss and glycemic control compared to single-pathway medications through its unique dual mechanism of action.
Comprehensive Dosing Guide
What is Tirzepatide?
Tirzepatide is a medication used to help manage type 2 diabetes and support weight loss in adults who are overweight or have obesity along with other health issues like high blood pressure or high cholesterol.
When is Tirzepatide Used?
Type 2 Diabetes:
- Helps control blood sugar levels.
- Can be used alone or with other diabetes medications.
Weight Loss:
- For adults with a Body Mass Index (BMI) of 30 or higher (obesity).
- For those with a BMI of 27 or higher (overweight) plus at least one weight-related health problem (like high blood pressure or diabetes).
Medical Disclaimer
Tirzepatide is FDA-approved as Mounjaro® for Type 2 diabetes and Zepbound® for chronic weight management. This information is for educational purposes and should not replace consultation with healthcare providers. Individual results may vary. Prescribing information and medical supervision are required for all therapeutic uses.